Interestingly, among the administered medications, the use of angiotensin-converting enzyme inhibitors was significantly different between patients with and without episodes of atrial fibrillation as detected by the AT-Patch device alone (n=4/11, 36.4% vs n=36/309, 11.7%, respectively; P=.04). Here, ACE is linked to atrial fibrillation.